ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer
暂无分享，去创建一个
Jenny C. Chang | W. Qian | A. Cohen | V. Kaklamani | T. Patel | J. Ensor | Xiaoxian Li | H. Wong | P. Niravath | T. Boone | J. Darcourt | A. Belcheva | P. Ramshesh | S. Nair | E. Koca | Pej Hemati | Jing Zhao | Asha Murthy | Jorge Darcourt | H. Wong